Skip to main content
. 2014 Dec 15;9(Suppl 2):109–126. doi: 10.2147/IJN.S57928

Figure 6.

Figure 6

Histopathological changes in the prostate gland after treatment with (A and B) ZnOAE100(−) and (C and D) ZnOAE100(+) at a dose of 500 mg/kg for 90 days. Prostate gland sections were stained with hematoxylin and eosin. (A and C) Control for the prostate gland tubule. (B and D) 500 mg/kg treatment groups.a

Note: aArrows in (B and D) show tubular hyperplasia in the prostate gland.

Abbreviations: A, suppurative inflammation, N, normal tubule; ZnO, zinc oxide; ZnOAE100(−), 100 nm negatively charged ZnO; ZnOAE100(+), 100 nm positively charged ZnO.